$SPRB CFO Sells $29K in Stock for RSU Tax Withholding
SPRUCE BIOSCIENCES, INC.
Subscribe to track SPRB
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
$SPRB CFO Sells $29K in Stock for RSU Tax Withholding
Company: SPRUCE BIOSCIENCES, INC. (SPRB) Form: 4 | Filed: 2025-12-17 Significance: Low
Insider: Gharib Samir M. Title: PRESIDENT AND CFO | Relationship: Officer
Transaction: • Type: Tax Withholding • Shares: 362 • Price: $80.67 • Value: $29,199 • Owned After: 8,263
Key Insight: This is a non-discretionary "sell-to-cover" transaction to satisfy tax obligations on newly vested Restricted Stock Units (RSUs). It does not represent a change in the insider's market sentiment.
Market Context: The transaction value represents approximately 0.027% of the company's $110 million market capitalization.
This is PUBLIC SEC data for educational purposes. Not investment advice.
Comprehensive Analysis
SEC Filing Analysis: SPRUCE BIOSCIENCES, INC. (SPRB)
Executive Summary
- Trading Significance: Low
- Key Takeaway: The President and CFO of Spruce Biosciences executed a routine, non-discretionary "sell-to-cover" transaction to pay taxes on vested Restricted Stock Units (RSUs).
- Market Impact: This transaction is unlikely to have any market impact as it is a common form of automated tax withholding and not an open-market sale reflecting insider sentiment.
Company Information
| Field | Value |
|---|---|
| Company | SPRUCE BIOSCIENCES, INC. |
| Ticker Symbol | SPRB |
| CIK | 0001683553 |
| Industry | PHARMACEUTICAL PREPARATIONS |
Insider Information
| Field | Value |
|---|---|
| Name | Gharib Samir M. |
| CIK | 0001533302 |
| Title/Position | PRESIDENT AND CFO |
| Relationship | Officer |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-12-15 |
| Transaction Code | F - Payment of exercise price or tax liability by delivering or withholding securities |
| Security Type | Common Stock |
| Shares Involved | 362 (aggregate of two 'F' transactions) |
| Price Per Share | $80.67 |
| Total Value | $29,198.54 |
| Shares Owned After | 8,263 |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $29,199 |
| % of Market Cap | 0.027% |
| Shares Transacted | 362 |
| % of Shares Outstanding | Data Not Available |
| Post-Transaction Ownership | 8,263 shares |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: The transaction value of ~$29k is negligible compared to Spruce Biosciences' market capitalization of $110 million.
- Ownership Concentration: Without shares outstanding data, the insider's ownership percentage cannot be calculated. However, the transaction itself is a minor event.
- Dilution Impact: The underlying event was the vesting of 1,009 RSUs (496 + 513), which were granted in prior years. The sale of 362 shares was solely to cover the associated tax liability.
- Transaction Significance: The transaction is classified as low significance. It is an automatic, non-discretionary sale required for tax purposes and does not indicate a voluntary decision by the insider to reduce their holdings.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: The market generally understands that 'sell-to-cover' transactions (Code F) are not indicative of an insider's outlook on the company's future performance. The value is also immaterial relative to the company's market cap.
Volume & Sentiment
- Expected Volume Impact: Negligible. The number of shares is too small to affect trading volume.
- Sentiment Indicator: Neutral. This type of filing is routine and does not typically influence market sentiment.
Additional Context
Transaction Notes
- Special Circumstances: The filing details two separate RSU vesting events occurring on the same day, both accompanied by a corresponding withholding of shares (Code 'F') to cover taxes. The net result for the insider was an increase of 647 shares of common stock.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
